Skip to content

Medical-device intelligence

Sekisui Diagnostics P.E.I. Inc.: FDA clearances and recalls

Research Sekisui Diagnostics P.E.I. Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

6 clearance records and 2 recall records in the covered releases, across 1 source company names and 6 product codes. Dated history runs from Dec 2, 2011 to Feb 18, 2022.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

8 matching records
Device / recordCompany in FDA recordSourceSource date
AcetaminophenK202644 · LDPSekisui Diagnostics P.E.I., Inc.510(k)Feb 18, 2022FDA decision date
SEKURE Creatine Kinase AssayK182702 · CGSSekisui Diagnostics P.E.I., Inc.510(k)Apr 17, 2019FDA decision date
SEKURE Acetaminophen L3K AssayK180835 · LDPSekisui Diagnostics P.E.I., Inc.510(k)Feb 8, 2019FDA decision date
SEKURE HbA1c AssayK173206 · PDJSekisui Diagnostics P.E.I., Inc.510(k)Jul 12, 2018FDA decision date
Sekisui Diagnostics Ammonia L3K Assay; Catalog Number: 293-80-91 and 293-10 For the IN VITRO quantitative measurement of ammonia concentration in…Z-1078-2017 · JIFSekisui Diagnostics P.E.I. Inc.RecallJan 23, 2017FDA classification date
DC-UIBC-CALK163078 · JITSekisui Diagnostics P.E.I., Inc.510(k)Dec 8, 2016FDA decision date
Sekure Chemistry Sekisui Diagnostics Acetaminophen L3K Assay, In-vitro Diagnostic Catalog Number: 506-10: R1: 1 x 10ml, R2: 2 x 10ml Catalog Num…Z-1171-2016 · LDPSekisui Diagnostics P.E.I. Inc.RecallMar 14, 2016FDA record creation date
MAGNESIUM ASSAYK111915 · JGJSekisui Diagnostics P.E.I., Inc.510(k)Dec 2, 2011FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗